0001209191-21-039957.txt : 20210611 0001209191-21-039957.hdr.sgml : 20210611 20210611173916 ACCESSION NUMBER: 0001209191-21-039957 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20210611 DATE AS OF CHANGE: 20210611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Croarkin Richard CENTRAL INDEX KEY: 0001641815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 211012476 MAIL ADDRESS: STREET 1: C/O AERIE PHARMACEUTICALS, INC. STREET 2: 2030 MAIN STREET, SUITE 1500 CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-10 0 0001539029 Clearside Biomedical, Inc. CLSD 0001641815 Croarkin Richard C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 Stock Option (right to buy) 3.11 2021-06-10 4 A 0 25000 0.00 A 2031-06-09 Common Stock 25000 25000 D The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 10, 2022. /s/ Brian F. Leaf, Attorney-in-Fact 2021-06-11